Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5857 posts found.

bacteria-3662695_960_720

Extremely antibiotic resistant superbugs spreading in hospitals across Europe

July 30, 2019 Manufacturing and Production AMR, Antibiotics, drug resistance, drug resistant bacteria, pharma

Antibiotic resistant superbugs are spreading in hospitals in Europe, according to a study published in Nature Microbiology. The research shows …
News
merck-keytruda

MSD’s Keytruda combo hits primary endpoint at Phase 3 in triple-negative breast cancer

July 30, 2019 Manufacturing and Production, Research and Development Cancer, MSD, breast cancer, keytruda, pharma

MSD’s blockbuster anti-PD-L1 immunotherapy Keytruda (pembrolizumab) has impressed in newly released Phase 3 data; the company announced that, when combined …
News
teva_copy

Teva, Endo and Teikoku pay $70 million settlement to California

July 30, 2019 Manufacturing and Production

Three pharmaceutical companies have agreed to pay $70 million to the state of California for keeping drug prices artificially high. …
News

Pfizer to combine off-patent drug unit Upjohn with Mylan

July 30, 2019 Manufacturing and Production M&A, MA, Mylan, Pfizer, Upjohn, biosimilars, generics, mergers

Pfizer’s off-patent drug unit Upjohn is combining with Mylan to create a new global pharmaceutical company focused on the low-price …
News
survey-2316468_640

The patient is always right: Extracting the full value of PROMs

July 29, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, PROs, UK, feature, patient reported outcomes, patient-reported outcomes, pharma

Patient-reported outcomes measures are an invaluable tool in ensuring that the patient remains in the driving seat when it comes …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 26, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biohaven, FDA, Lyrica, NICE, Pfizer, UK, US, pharma, top ten

At the end of a week that could certainly be called “eventful” here in the UK – one that saw …
News
reshma-bio-image

Vertex promote chief medical officer to CEO as Jeffrey Leiden steps down

July 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Reshma Kewalramani has been made the new Vertex CEO. Vertex’s Chief Medical Officer Dr Kewalramani will succeed current CEO …
Appointment
christi_shaw

Christi Shaw taken on by Gilead as Kite Pharma’s new CEO

July 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Lilly veteran Christi Shaw has joined Kite Pharma as the company’s new CEO. Shaw comes to Gilead’s cancer immunotherapy firm, …
Appointment
jonathan_symonds

GSK hire Jonathan Symonds as new Chairman

July 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Business chief Jonathan Symonds has joined British multinational GlaxoSmithKline as the company’s new non-executive chairman. The hire ends GSK’s six …
Appointment
mike-thompson-blue-bg

ABPI Chief Executive Mike Thompson to retire by the end of 2019

July 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Chief Executive Mike Thompson is to retire from his role at the Association of the British Pharmaceutical Industry (ABPI) by …
Appointment
dr_alvin_shih

Disarm Therapeutics hires Dr Alvin Shih as new President and CEO

July 23, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Massachusetts-based biotech Disarm Therapeutics has hired Dr Alvin Shih as their new President and CEO. The Cambridge, Mass.-based firm has …
Appointment
takeda_usa_pharmaceuticals_u

Takeda’s subcutaneous formulation of Entyvio smashes primary endpoint in Crohn’s disease

July 23, 2019 Manufacturing and Production, Research and Development Crohn’s disease, Entyvio, Takeda, crohn's disease, pharma

Takeda has unveiled new Phase 3 data for a subcutaneous formulation of its gut-selective biologic Entyvio (vedolizumab), showing that the …
News
bug_plants_insect_leaf_nature_macrophotography_naturephotography_macro-1046343

Drug resistant malaria spreads in South East Asia

July 23, 2019 Manufacturing and Production South East Asia, global health, infectious diseases, malaria, parasites

Drug resistant malaria parasites are spreading rapidly in South East Asia, according to researchers from Thailand and the United Kingdom. …
News

FDA approves nine generic versions of Pfizer’s Lyrica

July 23, 2019 Manufacturing and Production, Sales and Marketing FDA, Lyrica, Pfizer, pharma

The FDA has given its approval to the first generic versions of Pfizer’s Lyrica (pregabalin), it has emerged, giving the …
News
schizophrenia

Acadia’s schizophrenia drug flops in Phase 3 trial

July 23, 2019 Manufacturing and Production acadia, clinical trials, menatl health, neuroscience, pharma, phase 3, schizophrenia

Acadia Pharmaceuticals has said its schizophrenia drug Nuplazid (primavanserin) has failed to beat placebo in a Phase 3 trial. Nuplazid …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026